Neuromuscular Disorders Flashcards

1
Q

In general, what are Dystrophinopathies?

A

umbrella term for a spectrum of muscle disease caused by mutations to DMD (Xp21.2) which encodes dystrophin
they are progressive and symmetric
affect the proximal muscles (eg. hips, pelvic region, thighs, and shoulders)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the severe (classical) dystrophinopathies.

A

progressive skeletal (later cardiac) muscle disease:
Duchenne/Becker Muscle Dystrophy
progressive cardiac disease: DMD-associated dilated cardiomyopathy (DCM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the characteristics of milder forms of dystrophinopathies?

A

asymptomatic increase in [CK] and/or with muscle cramps, myoglobinuria, and isolated quad myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Duchenne Muscular Dystrophy?

A

“big hit” to the DMD gene
onset before 5 years of age
few patients survive past 30 years old (average lifespan in men: 24 y/o)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the symptoms of Duchenne Muscular Dystrophy?

A

delayed milestones (late to sit, stand, and walk)
toe-walking and flat footedness
wheelchair dependent before 13 y/o
gait problems
mild learning difficulties (short term verbal memory/executive function often confused with ADHD)
cardiomyopathy (1/3 by 14 y/o and all by 18 y/o)
calf hypertrophy (due to collections of proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Becker Muscular Dystrophy?

A

milder mutations of DMD
later onset of symptoms
mean survival 5th decade
some milder forms don’t manifest until 4th decade and are ambulatory until 7th decade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the symptoms of Becker Muscular Dystrophy?

A

weakness with calf hypertrophy
activity induced cramping
cardiac failure with DCM often appearing in adolescence (most often cause of death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the other forms of Becker Muscular Dystrophy?

A

BMD with subclinical skeletal muscle involvement

Benign skeletal muscle involvement with subclinical findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is DMD-associated Dilated Cardiomyopathy (DCM)?

A

DMD mutations that confer risk for DCM and heart failure without skeletal myopathy
males present in 2nd or 3rd decade
females present later (up to 20% of heterozygotes)
CK is elevated
some overlap with Becker Muscular Dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the normal serum [CK] for males with DMD and what percentage are affected?

A

> 10x normal

100% affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the normal serum [CK] for males with BMD and what percentage are affected?

A

> 5x normal

100% affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the normal serum [CK] for males with DMD associated DCM and how many are affected?

A

“increased”

most are affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the normal serum [CK] for females carriers of DMD and what percentage are affected?

A

2-10x normal

~50% affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the normal serum[CK] for female carriers of BMD and what percentage are affected?

A

2-10x normal

~30% affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What kinds of mutations cause dystrophinopathies and how frequent are they?

A
deletions (60-70%)
duplications (5-10%)
point mutations including small deletions and insertions, single base changes, and splicing mutations (25-30%)
nonsense more likely in DMD
missence rare in both DMD and BMD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the possible dystrophin transcripts that come from the DMD gene and what tissues are they found in?

A

full length DP427 (brain, muscle, Purkinje)
From exon 30 DP260 (retina)
*Exons 45-50 DP140 (brain and kidney)
Fron exon 56 DP116 (Schwann cell)
From exon 63 DP71 (ubiquitous except for muscle; increased in brain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the genotype-phenotype correlation for DMD.

A

occurs when there is little to no dystrophin produced
caused by out of frame deletions (usually large)
nonsense mutations
some missense and splicing mutations (disrupt reading frame)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the genotype-phenotype correlation for BMD.

A

occurs when some dystrophin is produced or normal amount is produced but is partially functional
many in-frame del/dups
splicing and missense mutations (less disruptive)
most non-truncating single-base changes that confers a protein product with intact N and C termini

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the genotype-phenotype correlation for DMD-associated DCM.

A

mutations affect muscle promoter and 1st exon (leading to no dystrophin transcripts in muscle)
2 alternate promoters active in skeletal muscle –> dystrophin expression sufficient to prevent manifestation of skeletal muscle disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What signs and symptoms are present in female heterozygotes with DMD?

A
none (75%)
muscle weakness (19%)
myalgia/cramps (5%)
LV dilation (19%)
dilated cardiomyopathy (8%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What signs and symptoms are present in female heterozygotes with BMD?

A
none (81%)
muscle weakness (14%)
myalgia/cramps (5%)
LV dilation (16%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the molecular causes of females with “classic” DMD?

A

deletion of Xp21.2
UPD of chromosome X
45X karyotype
skewed X inactivation
X chromosome rearrangement involving Xp21.2
compound heterozygotes for 2 DMD mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How are dystrophinopathies managed/treated?

A

PT
developmental/educational evaluations
ECHO/EKG/Cardiac MRI (by age 6)
prednisone
perioperative care (malignant hyperthermia precautions)
pulmonary function testing
ACE inhibitors + beta blockers (for dilated cardiomyopathy)
Ataluren
Aminoglycosides (weekly/biweekly gentamicin)

24
Q

What other conditions are on the ddx when a patient presents with dystrophinopathy symptoms?

A

Limb Girdle Muscular Dystrophy

Emery-Dreifuss Muscular Dystrophy

25
Q

What is Limb Girdle Muscular Dystrophy?

A

heterogenous group of progressive muscular dystrophies

16 different genes implicated (6 AD 10 AR)

26
Q

What are the symptoms of Limb Girdle Muscular Dystrophy?

A

predominately associated with weakness of pelvic girdle and should girdle (difficulty rising from chair and raising arms above head)
LGMD1B disease associated with DMC in some cases
Elevated CK

27
Q

How do you diagnose Limb Girdle Muscular Dystrophy?

A

cardiac evaluation with ECG and ECHO
muscle biopsy with immunohistostaining
not specific but will give you likely groups
DNA testing (standard of care)

28
Q

What is Emery-Dreifuss Muscular Dystrophy?

A

X-Linked (EMD) or AD (lamin A/C LMNA locus) or AR (LMNA) laminopathy
typically childhood onset
generally present with toe walking, flexed elbows, progressive weakness, and wasting in distinctive humeroperoneal distribution

29
Q

What are the symptoms associated with XL Emery-Dreifuss Muscular Dystrophy?

A

early contractures at elbows/achilles (progressive weakness)

30
Q

What are the symptoms associated with AD Emery-Dreifuss Muscular Dystrophy?

A

cardiac conduction defects and DCM more common

31
Q

What are the symptoms associated with AR Emery-Dreifuss Muscular Dystrophy?

A

rare

early onset and severe

32
Q

What is Facioscapulohumeral Muscular Dystrophy 1?

A

AD
deletion of integral number of tandem repeats (3.3 kb each) on 4q35 resulting in a “permissive” chromosome 4
small portion of de novo D4Z4 contraction

33
Q

What are the symptoms associated with Facioscapulohumeral Muscular Dystrophy?

A

weakness in facial muscles, dorsiflexors, and scapular muscles (starting around age 20)
hip girdle may be affected in more advanced/severe disease
other associated hearing impairments
asymptomatic retinal vasculopathy

34
Q

How is Facioscapulohumeral Muscular Dystrophy diagnosed?

A

CK normal or mildly elevated (rarely 3-5x normal)

DNA test to confirm

35
Q

What is Facioscapulohumeral Muscular Dystrophy 2?

A

inherited in a digenic pattern where two independent gene changes a mutation in SMCHD1 gene (chromosome 18) and separately an inherited “permissive” chromosome 4
when deactivated, SMCHD1 results in hypomethylated D4Z4 repeat array (normal repeats) but still hypomethylated and continuously active

36
Q

What is Myotonic Dystrophy?

A

most common AD neuromuscular disorder
extreme variability
anticipation present (full mutations more likely to expand when maternally inherited; protomutations more likely to expand to full mutations when paternally inherited)
expansion of CTG triplet in 3’ UTR of DMPK gene (19q13.3)
OR
CUG expansion in DNA –> toxic gain of function of abnormally stored RNA, deregulated RNA binds protein and mRNA splicing process which disrupts other genes

37
Q

What are the symptoms associated with Myotonic Dystrophy?

A

cannot quickly open clenched fist
myotonic facies (ptosis, mouth hangs open, atrophic, and weak SCMs)
frontal balding
cataracts
weak wrist extension
myotonic contractions with tapping thenar eminence
reflexes initially normal but may become reduced or absent

38
Q

Describe the genotype phenotype correlation between the number of repeats for Myotonic Dystrophy.

A

normal repeats (no symptoms): 4-37
premutation (no symptoms): 38-49
protomutation (asymptomatic or mild, late onset disease): 50-80
mutation (onset 3rd or 4th decade): 200-500
mutation (childhood onset but not congenital): 230-1800
mutation (congenital myotonic dystrophy presenting at birth): 1000+

39
Q

What are the symptoms associated with Congenital Myotonic Dystrophy?

A

polyhuraminios
floppy at birth
respiratory issues requiring ventilator support
feedign issues
facial diplegia with tented mouth
mortality 20% in neonatal period
most surviving children have significant learning disabilities

40
Q

What is Proximal Myotonic Myopathy (PROMM)?

A

“Myotonic Dystrophy Type II”
AD
may be clinically indistinguishable from myotonic dystrophy (has proximal weakness with mild myotonia)
(CCTG)n expansion on 2NF9 (chromosome 3)
Type 2 fiber atrophy predominates on muscle biopsy

41
Q

What are Congenital Myopathies?

A

non-progressive collection of diverse genotypes and phenotypes
diagnosed first by checking most to least common etiologies
includes Nemaline myopathy

42
Q

What are Congenital Myasthenic Syndromes?

A
affect neuromuscular junction (defects affect communication between neuron and muscle)
rare
most AR
myasthenic or congenital
has some autoimmune forms
43
Q

What are the autoimmune forms of Congenital Myasthenic Syndromes?

A

Transient Neonatal Myesthenia Gravis

Juvenile to Adult Onset Myasthenia Gravis

44
Q

What symptoms are associated with Myasthenic forms of Congenital Myasthenic Syndromes?

A

weakness or fatigue that varies through the day (worse with exertion)
can involve eye and facial muscles, swallowing, or respiration
generally respond to anticholinesterase

45
Q

List the characteristics of Congenital forms of Congenital Myasthenic Syndromes?

A

early onset
normally have positive family history (usually an affected sibling)
absence of anti-Arch R and anti-MUSK AB
peculiar EMG pattern (repetitive responses)

46
Q

What is Spinal Muscular Atrophy?

A

AR
SMN1 (5q13) and SMN2 involved
homozygous deletion (zero functioning copies) of SMN1 is causative
>2 functioning copies of SMN2 is protective (results in milder phenotype or silent carriers)
carrier testing and counseling is complicated

47
Q

What symptoms are associated with Spinal Muscular Atrophy?

A

global hypotonia and paralysis (nothing against gravity)
anterior horn cell degradation
reduced tone and absent reflexes
normal CK and normal cognition

48
Q

What are the possible phenotypes of Spinal Muscular Atrophy?

A

Type 0: severe, prenatal onset arthrogryposis and respiratory compromise at birth
Type 1 (Werdnig-Hoffman): onset of weakness and hypotonia before 6 months; never able to sit or walk; fatal respiratory failure by age 2 typically
Type 2: onset before 12 months; sit but never walk
Type 3 (Kugelberg-Welander): onset later in childhood, walk initially, survive to adulthood
Type 4: adult onset

49
Q

What are the symptoms of Congenital Muscular Dystrophies?

A

muscle weakness (dystrophic muscles on biopsy)
onset at birth or early infancy
elevated CPK
most with brain/CNS involvement
most AR
rare
abnormal brain MRIs (not just in the cortex- also white spots in cerebellum)

50
Q

What is the work-up protocol for Neuromuscular Disorders?

A
CPK
ECHO
EKG
Pulmonary Function Testing
EMG
Nerve Conduction Study
muscle biopsy
MRI of brain and/or spine
DNA testing (first for DMD, SMA, DM1, DM2, FSHD)
51
Q

What are the diagnostic findings consistent with Duchenne and Becker Muscular Dystrophy?

A

Plasma CK: >10x normal in DMD
EMG: short duration, low amp, polyphasic, rapidly recruited motor APS, electrically silent later
Muscle Biopsy: variable size, foci of necrosis and regeneration (early), deposition of fat and connective tissue (late); plasticity/absence of dystrophin

52
Q

What are the diagnostic findings consistent with Myotinic Dystrophy?

A

Plasma CK: usually normal
EMG: myotonic discharges in distal muscles
Muscle Biopsy: Type 1 fiber predominance/atrophy

53
Q

What are the diagnostic findings consistent with Spinal Muscular Atrophy?

A

Plasma CK: usually normal or mildly elevated
EMG: spontaneous motor unit activity, characteristic denervation, and diminished motor AP amplitude
Muscle Biopsy: atrophy of both types 1 and 2 fibers; rare large fibers

54
Q

How are Neuromuscular Disorders generally managed?

A

orthopedics (bracing, contracture release, scoliosis care)
cardiology
pulmonology/ENT
neurology (for pts with seizures, global delays, and spasticity)
general surgeon (for possible G-tube placement)
psychiatric support
palliative care

55
Q

What medications should be avoided for all Neuromuscular patient?

A

anesthesia
inhaled (increased risk of rhabdomyolysis and malignant hyperthermia in pts with muscle involvement)
succinylcholine (risk for hyperkalemia)
any non-polarizing paralytic agent (prolonged paralysis and weakness; need for prolonged ventilation)
any sedative (risk for prolonged weakness and delirium)